Mccormick & Company, Inc. — Turkey Cooking Stock
by McCormick & Company, Inc.MRT 176 Panel Triggers Identified
Clinical Product Assessment
Mccormick & Company, Inc. manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 8 MRT-tested substances, including multiple animal proteins and vegetable bases. The presence of ‘natural flavour’, ‘spices’, and ‘spice extractives’ introduces unknown variables. Due to the high number of triggers, this product is unsuitable for the early phases of the ImmunoCalm® protocol.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 8
- Safe Ingredients: 3
- Unknown/Ambiguous: 3 (natural flavour, spices, spice extractives)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| concentrated turkey stock | Turkey | Direct Match |
| concentrated chicken stock | Chicken | Direct Match |
| carrot | Carrot | Direct Match |
| onion | Onion | Direct Match |
| celery | Celery | Direct Match |
| mushroom | Mushroom | Direct Match |
| honey | Honey | Direct Match |
| soybean oil | Soybean | Direct Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel: natural flavour, spices, spice extractives. Patients should treat these as potential triggers until MRT testing confirms safety.
LEAP Protocol Guidance
With 8 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist.
UPC Code: 611443440263
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Turkey is tested as an individual poultry protein on the MRT panel. It includes all turkey-derived ingredients such as turkey broth, turkey stock, and deli turkey.
Chicken is tested independently from other poultry on the MRT panel. Cross-reactivity with turkey or eggs is not assumed — each is measured separately.
Carrot is an individually tested vegetable on the MRT panel. Found in soups, baby food, juice blends, and many vegetable-based processed foods. Related to celery in the Apiaceae family.
Onion is tested as a standalone substance on the MRT panel. It appears in seasonings, soups, sauces, and most savory processed foods. Often hidden as "dehydrated onion" or "onion powder" in spice blends.
Celery is tested on the MRT panel and recognized as a major allergen in Europe. Found in soups, spice blends, and Bloody Mary mixes. Celery seed and celery salt also contain the reactive proteins.
Honey is tested as a distinct substance on the MRT panel. It contains proteins that can trigger mediator release independently of its sugar content. Found in many "natural" sweetened products.
Soy-derived ingredients appear in a wide range of processed foods including soy lecithin, soybean oil, and textured soy protein. One of the most prevalent hidden triggers.
What This Means For Your Diet
With 8 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 8 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from McCormick & Company, Inc.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners